COL1A2, COL1A1, COL6A3, and SDC1 were expressed at higher levels in tumor tissue compared with normal tissue in the TCGA-BC, TCGA-CRC, and TCGA-ESCA datasets (Figure 5e). This evidence concerns the gene COL6A3 and breast cancer.